01 1PolyPeptide SA
01 1Eguzenataido
01 1Switzerland
Registration Number : 223MF10041
Registrant's Address : Chausse(')e de Tubize 297, Braine-L'Alleud, 1420, Belgium
Initial Date of Registration : 2011-03-10
Latest Date of Registration : 2016-10-19
44
PharmaCompass offers a list of Exenatide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Exenatide manufacturer or Exenatide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Exenatide manufacturer or Exenatide supplier.
PharmaCompass also assists you with knowing the Exenatide API Price utilized in the formulation of products. Exenatide API Price is not always fixed or binding as the Exenatide Price is obtained through a variety of data sources. The Exenatide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ex4 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ex4, including repackagers and relabelers. The FDA regulates Ex4 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ex4 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ex4 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ex4 supplier is an individual or a company that provides Ex4 active pharmaceutical ingredient (API) or Ex4 finished formulations upon request. The Ex4 suppliers may include Ex4 API manufacturers, exporters, distributors and traders.
click here to find a list of Ex4 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ex4 Drug Master File in Japan (Ex4 JDMF) empowers Ex4 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ex4 JDMF during the approval evaluation for pharmaceutical products. At the time of Ex4 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ex4 suppliers with JDMF on PharmaCompass.
